2025 年葡萄糖生物感测器全球市场报告

预计未来几年葡萄糖生物感测器的市场规模将快速成长。到 2029 年，这一数字将成长至 275.4 亿美元，复合年增长率为 13.1%。预测期内的成长可归因于个人化的医疗保健解决方案、糖尿病患者数量的增加、持续血糖监测的扩展、与穿戴式技术的整合以及非侵入性监测的发展。预测期内的主要趋势包括环保生物感测器设计、互联互通和资料共用、增强型家庭医疗保健、非侵入性监测技术和可植入生物感测器。

预计未来几年糖尿病盛行率的上升将推动葡萄糖生物感测器市场的成长。糖尿病是一种慢性疾病，当胰臟无法产生足够的胰岛素或身体无法有效利用产生的胰岛素时就会发生。透过使用葡萄糖生物感测器定期监测血糖值，糖尿病患者可以更有效地管理病情并在必要时调整药物。例如，2024 年 6 月，英国管理机构 NHS England 报告称，2023 年在 GP 处登记的 3,615,330 人被确诊患有非糖尿病性高血糖症（通常称为糖尿病前期），高于 2022 年的 3,065,825 人，增幅近 18%。因此，糖尿病盛行率的上升是推动葡萄糖生物感测器市场扩张的关键因素。

老年人口的增加预计将促进葡萄糖生物感测器市场的成长。老龄化社会的特征是老年人比例不断增加，葡萄糖生物感测器可帮助人们透过早期检测、远端监控和全面的健康管理来有效管理糖尿病。根据世界卫生组织（WHO）2022年10月的报告，到2030年，全球整体每六人中就有一人年龄超过60岁，到2050年这个年龄层的人口将达到21亿人。在英国，根据英国国会下院图书馆2021年6月发布的预测，到2043年老年人口将占总人口的24%，达到1,740万人。因此，老年人口的增加是推动葡萄糖生物感测器市场成长的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球葡萄糖生物感测器市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球葡萄糖生物感测器市场：成长率分析
• 全球葡萄糖生物感测器市场表现：规模与成长，2019 年至 2024 年
• 全球葡萄糖生物感测器市场预测：规模与成长，2024-2029 年，2034 年
• 全球葡萄糖生物感测器总目标市场 (TAM)

第六章 市场细分

• 全球葡萄糖生物感测器市场按产品类型、性能和预测，2019-2024、2024-2029、2034
• 持续血糖监测
• 自我血糖监测
• 非侵入性血糖监测
• 全球葡萄糖生物感测器市场技术、性能及预测，2019-2024、2024-2029、2034
• 电化学生物感测器
• 光学生物感测器
• 压电生物感测器
• 其他的
• 全球葡萄糖生物感测器市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 居家护理
• 诊断中心和诊所
• 其他的
• 全球葡萄糖生物感测器市场：持续葡萄糖监测 (CGM) 细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 即时 CGM 系统
• 专业 CGM 系统
• 胰岛素帮浦集成
• 感测器类型
• 全球葡萄糖生物感测器市场：自我血糖监测 (SMBG) 细分市场按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 血糖仪
• 测试条
• 血液样本类型
• 全球葡萄糖生物感测器市场：非侵入式血糖监测细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
• 光学葡萄糖感测器
• 经皮感应器
• 穿戴式装置

第七章 区域和国家分析

• 全球葡萄糖生物感测器市场各地区、绩效及预测，2019-2024、2024-2029、2034
• 全球葡萄糖生物感测器市场（依国家划分）、绩效及预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 葡萄糖生物感测器市场：竞争格局
• 葡萄糖生物感测器市场：公司简介
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Trividia Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Bayer AG
• LifeScan Inc.
• Medtronic plc
• Nova Biomedical Corporation
• Senseonics Holdings
• ACON Laboratories Inc.
• AgaMatrix Inc.
• Ypsomed AG
• Ascencia Diabetes Care Holdings Inc.
• Bio-Rad Laboratories Inc.
• DuPont de Nemours Inc.
• Biosensors International Group Ltd.
• Cytiva
• Universal Biosensors Inc.
• CARDEA BIO INC.

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年葡萄糖生物感测器市场：提供新机会的国家
• 2029 年葡萄糖生物感测器市场：细分市场将带来新机会
• 2029 年葡萄糖生物感测器市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

A glucose biosensor is a specialized device designed for measuring glucose levels in different samples, commonly found in biological fluids such as blood or interstitial fluid. Widely applied in healthcare, especially for diabetes management, these biosensors facilitate convenient and frequent monitoring of blood glucose levels.

The primary product categories for glucose biosensors include continuous glucose monitoring, self-monitoring blood glucose, and non-invasive glucose monitoring. Continuous glucose monitoring (CGM) involves using a miniature sensor implanted under the skin to measure glucose levels in the patient's body. This method offers a more comprehensive view of glucose levels compared to standard fingerstick glucose monitoring and provides real-time results. The technologies predominantly used are electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others. These biosensors find applications across various end-users such as hospitals, home care, diagnostic centers, clinics, and others.

The glucose biosensors market research report is one of a series of new reports from The Business Research Company that provides glucose biosensors market statistics, including glucose biosensors industry global market size, regional shares, competitors with a glucose biosensors market share, detailed glucose biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the glucose biosensors industry. This glucose biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glucose biosensors market size has grown rapidly in recent years. It will grow from$15.26 billion in 2024 to $16.85 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to research and development, cost-efficiency, user-friendly design, increasing diabetes prevalence, integration with smart devices, non-invasive monitoring techniques

The glucose biosensors market size is expected to see rapid growth in the next few years. It will grow to $27.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to personalized healthcare solutions, rise in diabetes cases, continuous glucose monitoring expansion, integration with wearable tech, non-invasive monitoring development. Major trends in the forecast period include eco-friendly biosensor designs, interconnectivity and data sharing, home healthcare empowerment, non-invasive monitoring techniques, implantable biosensors.

The increasing prevalence of diabetes is projected to drive the growth of the glucose biosensors market in the coming years. Diabetes is a chronic condition that occurs when the pancreas does not produce sufficient insulin or when the body is unable to effectively use the insulin produced. Patients with diabetes rely on glucose biosensors to regularly monitor their blood glucose levels, allowing them to manage their condition more effectively and adjust their medication as needed. For example, in June 2024, NHS England, a governing body in the UK, reported that in 2023, 3,615,330 individuals registered with a GP were identified as having non-diabetic hyperglycemia, commonly known as pre-diabetes, which reflects an increase from 3,065,825 in 2022-an almost 18% rise. Therefore, the growing prevalence of diabetes is a significant factor driving the expansion of the glucose biosensors market.

The increasing aging population is anticipated to contribute to the growth of the glucose biosensor market. The aging population, characterized by a rising proportion of elderly individuals, benefits from glucose biosensors that support effective diabetes management through early detection, remote monitoring, and overall well-being. According to the World Health Organization's October 2022 report, globally, one in six people will be 60 or older by 2030, with the number of individuals in this age group reaching 2.1 billion by 2050. In the United Kingdom, projections from the UK Parliament's House of Commons Library in June 2021 indicate that by 2043, the senior population will constitute 24% of the total population, amounting to 17.4 million people. Therefore, the growing aging population is a significant factor driving the growth of the glucose biosensor market.

Leading companies in the glucose biosensor market are concentrating on innovative product launches, particularly glucose monitoring systems, to assist individuals with diabetes. These systems are designed to continuously measure and provide real-time data on blood glucose levels, helping individuals manage their condition more effectively. For instance, in October 2024, DexCom Inc., a biotechnology company based in the United States, introduced the Stelo Glucose Biosensor System. This system is notable for being the first over-the-counter (OTC) continuous glucose monitor (CGM) approved by the U.S. Food and Drug Administration (FDA). The Stelo system is intended for adults aged 18 and older who do not use insulin, including those with Type 2 diabetes or prediabetes. It can also be utilized by individuals without diabetes who want to monitor their glucose levels to better understand how their diet and exercise impact blood sugar.

Major companies in the glucose biosensor market are emphasizing innovative product launches, exemplified by the introduction of the GlucoMen Day continuous glucose monitoring (CGM) system, to diversify their product portfolio and broaden market outreach. The GlucoMen Day CGM system, a real-time subcutaneous continuous glucose monitoring system, is designed to assist individuals with diabetes in effectively managing their blood sugar levels. This system offers a more convenient and accurate alternative for tracking glucose fluctuations compared to traditional finger-pricking methods. In April 2022, 77 Elektronika Kft., a Hungary-based medical equipment manufacturer, introduced the glucomen day continuous glucose monitoring (CGM) system in collaboration with A. Menarini Diagnostics, an Italy-based diagnostics company. The glucomen day CGM system represents a notable advancement in diabetes management technology, providing users with valuable insights into their glucose levels and empowering them to make informed decisions for better diabetes control. This innovative system has the potential to enhance the quality of life for people with diabetes and alleviate the burden of this chronic condition.

In May 2023, Medtronic plc, an Ireland-based medical device company, completed the acquisition of EOFLOW Co., Ltd. for $738 million. Through this strategic acquisition, Medtronic plc aims to broaden treatment options, cater to the demand for discreet delivery, and strengthen its position in the market. EOFLOW Co. Ltd. is a South Korea-based medical device company specialized in developing and manufacturing wearable drug delivery systems.

Major companies operating in the glucose biosensors market include Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, GlySens Incorporated, Trividia Health, Bayer AG, LifeScan Inc., Medtronic plc, Nova Biomedical Corporation, Senseonics Holdings, ACON Laboratories Inc., AgaMatrix Inc., Ypsomed AG, Ascencia Diabetes Care Holdings Inc., Bio-Rad Laboratories Inc., DuPont de Nemours Inc., Biosensors International Group Ltd., Cytiva, Universal Biosensors Inc., CARDEA BIO INC., Conductive Technologies Inc., EarlySense Inc., Innovative Sensor Technology IST AG, LifeSignals Inc., NeuroSky Inc., SD Biosensor INC., Xsensio, Taidoc Technology Corporation

North America was the largest region in the glucose biosensors market in 2024. The regions covered in the glucose biosensors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the glucose biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The glucose biosensors market consists of sales of magnetic biosensors, thermometric biosensors, potentiometric, amperometric, and conductometric sensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glucose Biosensors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glucose biosensors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glucose biosensors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glucose biosensors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Continuous Glucose Monitoring; Self-monitoring Blood Glucose; Non-invasive Glucose Monitoring
• 2) By Technology: Electrochemical Biosensors; Optical Biosensors; Piezoelectric Biosensors; Others Technologies
• 3) By End Users: Hospitals; Home Care; Diagnostic Centers and Clinics; Other End Users
• Subsegments:
• 1) By Continuous Glucose Monitoring (CGM): Real-time CGM systems; Professional CGM systems; Integration with insulin pumps; Sensor types
• 2) By Self-monitoring Blood Glucose (SMBG): Glucometers; Test strips; Blood sample types
• 3) By Non-invasive Glucose Monitoring: Optical glucose sensors; Transdermal sensors; Wearable devices
• Companies Mentioned: Abbott Laboratories; DexCom Inc.; F. Hoffmann-La Roche AG; GlySens Incorporated; Trividia Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glucose Biosensors Market Characteristics

3. Glucose Biosensors Market Trends And Strategies

4. Glucose Biosensors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Glucose Biosensors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Glucose Biosensors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Glucose Biosensors Market Growth Rate Analysis
• 5.4. Global Glucose Biosensors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Glucose Biosensors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Glucose Biosensors Total Addressable Market (TAM)

6. Glucose Biosensors Market Segmentation

• 6.1. Global Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Glucose Monitoring
• Self-monitoring Blood Glucose
• Non-invasive Glucose Monitoring
• 6.2. Global Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrochemical Biosensors
• Optical Biosensors
• Piezoelectric Biosensors
• Other Technologies
• 6.3. Global Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Home Care
• Diagnostic Centers and Clinics
• Other End Users
• 6.4. Global Glucose Biosensors Market, Sub-Segmentation Of Continuous Glucose Monitoring (CGM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-time CGM systems
• Professional CGM systems
• Integration with insulin pumps
• Sensor types
• 6.5. Global Glucose Biosensors Market, Sub-Segmentation Of Self-monitoring Blood Glucose (SMBG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glucometers
• Test strips
• Blood sample types
• 6.6. Global Glucose Biosensors Market, Sub-Segmentation Of Non-invasive Glucose Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Optical glucose sensors
• Transdermal sensors
• Wearable devices

7. Glucose Biosensors Market Regional And Country Analysis

• 7.1. Global Glucose Biosensors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Glucose Biosensors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glucose Biosensors Market

• 8.1. Asia-Pacific Glucose Biosensors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glucose Biosensors Market

• 9.1. China Glucose Biosensors Market Overview
• 9.2. China Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glucose Biosensors Market

• 10.1. India Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glucose Biosensors Market

• 11.1. Japan Glucose Biosensors Market Overview
• 11.2. Japan Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glucose Biosensors Market

• 12.1. Australia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glucose Biosensors Market

• 13.1. Indonesia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glucose Biosensors Market

• 14.1. South Korea Glucose Biosensors Market Overview
• 14.2. South Korea Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glucose Biosensors Market

• 15.1. Western Europe Glucose Biosensors Market Overview
• 15.2. Western Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glucose Biosensors Market

• 16.1. UK Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glucose Biosensors Market

• 17.1. Germany Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glucose Biosensors Market

• 18.1. France Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glucose Biosensors Market

• 19.1. Italy Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glucose Biosensors Market

• 20.1. Spain Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glucose Biosensors Market

• 21.1. Eastern Europe Glucose Biosensors Market Overview
• 21.2. Eastern Europe Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glucose Biosensors Market

• 22.1. Russia Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glucose Biosensors Market

• 23.1. North America Glucose Biosensors Market Overview
• 23.2. North America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glucose Biosensors Market

• 24.1. USA Glucose Biosensors Market Overview
• 24.2. USA Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glucose Biosensors Market

• 25.1. Canada Glucose Biosensors Market Overview
• 25.2. Canada Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glucose Biosensors Market

• 26.1. South America Glucose Biosensors Market Overview
• 26.2. South America Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glucose Biosensors Market

• 27.1. Brazil Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glucose Biosensors Market

• 28.1. Middle East Glucose Biosensors Market Overview
• 28.2. Middle East Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glucose Biosensors Market

• 29.1. Africa Glucose Biosensors Market Overview
• 29.2. Africa Glucose Biosensors Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Glucose Biosensors Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Glucose Biosensors Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glucose Biosensors Market Competitive Landscape And Company Profiles

• 30.1. Glucose Biosensors Market Competitive Landscape
• 30.2. Glucose Biosensors Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlySens Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Trividia Health Overview, Products and Services, Strategy and Financial Analysis

31. Glucose Biosensors Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. LifeScan Inc.
• 31.3. Medtronic plc
• 31.4. Nova Biomedical Corporation
• 31.5. Senseonics Holdings
• 31.6. ACON Laboratories Inc.
• 31.7. AgaMatrix Inc.
• 31.8. Ypsomed AG
• 31.9. Ascencia Diabetes Care Holdings Inc.
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. DuPont de Nemours Inc.
• 31.12. Biosensors International Group Ltd.
• 31.13. Cytiva
• 31.14. Universal Biosensors Inc.
• 31.15. CARDEA BIO INC.

32. Global Glucose Biosensors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glucose Biosensors Market

34. Recent Developments In The Glucose Biosensors Market

35. Glucose Biosensors Market High Potential Countries, Segments and Strategies

• 35.1 Glucose Biosensors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Glucose Biosensors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Glucose Biosensors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer